| Barchart Demo Center |
$2,22
+0,09 (+4,23%)
en date du mai 31, 2024
en date du mai 31, 2024
| Dernière | 2,22 |
|---|---|
| Variation | +0,09 (+4,23%) |
| Ouverture | 2,11 |
| Clôture précédente | 2,13 |
| Écart (actuel) |
2,10
2,22
|
| Écart 52 semaines |
1,84
4,50
|
| Volume | 10 400 |
| Volume Moyen | 12 720 |
| Secteur | SIC-2834 Pharmaceutical Preparations |
Perfomance Comparison
| Nom | Aujourd'hui | 3-mois | 1 an |
|---|---|---|---|
| TXMD |
 +4,23% |
 -5,53% |
 -42,49% |
| DJIA |
 +1,51% |
-2,09% |
+16,90% |
| S&P 500 |
+0,80% |
+1,01% |
+25,49% |
Statistiques clef
| BPA Annuel | N/A |
|---|---|
| Rendement dividendes | 0,00% |
| Rapport Prix/Bénéfices | N/A |
| Market Capitalization, $K | 25 140 |
| Alpha pondéré | -45,39 |
| Écart-type | +1,73 |
| Marge d'exploitation | N/A |
| Beta | 1,07 |
Taux de croissance
| Cette année | -1,33% | |||
| 1 An(s) | -49,55% | |||
| 3 An(s) | -96,33% | |||
| 5 An(s) | -98,59% | |||
| 10 An(s) | -98,91% |
Opinion
| Vendre | Conserver | Acheter |
Articles récents
TherapeuticsMD: Q1 Earnings Snapshot
AP - Fri May 10, 03:43PM CDT
TherapeuticsMD: Q1 Earnings Snapshot(version intégrale)
TXMD: 2,22 (+0,09)
TherapeuticsMD Announces First Quarter 2024 Financial
Business Wire - Fri May 10, 03:05PM CDT
TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the first quarter ended March 31, 2024.(version intégrale)
TXMD: 2,22 (+0,09)
TherapeuticsMD Announces Full Year 2023 Financial
Business Wire - Fri Mar 29, 03:00PM CDT
TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023.(version intégrale)
TXMD: 2,22 (+0,09)
TherapeuticsMD: Q3 Earnings Snapshot
AP - Wed Nov 15, 04:08AM CST
TherapeuticsMD: Q3 Earnings Snapshot(version intégrale)
TXMD: 2,22 (+0,09)
TherapeuticsMD Announces Third Quarter 2023 Financial
Business Wire - Tue Nov 14, 03:05PM CST
TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the third quarter ended September 30, 20(version intégrale)
TXMD: 2,22 (+0,09)